EUVIMEDEUVIMED entdecken
Vergleichsstudie

A cross-country comparison of the psychometric performance of SF-6Dv2 and EQ-5D-5L

Hosein Ameri, Brendan Mulhern, Richard Norman, Takeru Shiroiwa, Rajabali Daroudi, Thomas G Poder

The European Journal of Health Economics · 2025

DOI: 10.1007/s10198-025-01867-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The European Journal of Health Economics, 2025. Verfasst von Hosein Ameri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of management, evaluation and health policy, School of Public Health, University of Montreal, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Psychometrics, Quality of Life, Health Status. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the comparative performance of SF-6Dv2 and EQ-5D-5L in the general population of Quebec (Canada), Tehran (Iran), and Japan. METHODS: Data on SF-6Dv2 and EQ-5D-5L were collected in the three countries. Descriptive differences in utility values between SF-6Dv2 and EQ-5D-5L were assessed using t-tests, as well as ceiling effects were evaluated based on the percentage of "no problem" levels reported. The known-group validity of both measures was assessed by comparing utility scores across health and demographic subgroups using t-tests or ANOVA and by calculating effect sizes across known groups. The area under the receiver operating characteristic curve (AUROC) analysis and F-statistic ratios were used to further validate the findings from the known-group validity analyses. Convergent validity for both instruments was assessed using Spearman's rank correlation coefficient. The agreement between instruments was evaluated using intraclass correlation coefficients (ICC) and Bland-Altman plots. RESULTS: A total of 2,378 respondents for Quebec, 3,061 for Tehran, and 3,933 for Japan were included. Differences in utility values between SF-6Dv2 and EQ-5D-5L were statistically significant, with SF-6Dv2 generally yielding lower utility scores. Both instruments demonstrated strong known-group validity, effectively distinguishing between diseased and healthy groups as well as various demographic characteristics. However, EQ-5D-5L outperformed SF-6Dv2 for most demographic characteristics based on AUROC analysis and F-statistic ratios. In contrast, their performance in distinguishing between healthy and diseased groups did not favor a particular instrument. Convergent validity analyses indicated strong associations between SF-6Dv2 and EQ-5D-5L utility values in Quebec (0.760) and Tehran (0.737). The agreement between SF-6Dv2 and EQ-5D-5L utility values was moderate in Quebec (0.69) and strong in Tehran (0.837). Bland-Altman plots indicated that differences between the two instruments tended to increase as the average score decreased. CONCLUSION: Both EQ-5D-5L and SF-6Dv2 demonstrated favorable psychometric performance in terms of known-group validity and convergent validity. These findings suggest that both instruments are valid tools for health utility measurement for use in general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsychometricsQuality of LifeHealth StatusHumansIranFemaleReproducibility of ResultsMaleQuebecSurveys and QuestionnairesAdultMiddle AgedJapanROC CurveAgedYoung AdultAdolescent

Stichwörter der Autor:innen

EQ-5D-5LHealth-related quality of lifePsychometric propertiesSF-6Dv2

Autor:innen und Institutionen

  • Department of management, evaluation and health policy, School of Public Health, University of Montreal, Montreal, QC, Canada.
  • CR-IUSMM, CIUSSS de l'Est de l'Ile de Montréal, Montreal, QC, Canada.
  • University of Technology Sydney, Sydney, Australia.
  • School of Population Health, Curtin University, Perth, Australia.
  • Center for Outcomes Research and Economic Evaluation for Health (C2H), National Institute of Public Health, Saitama, Japan.
  • Department of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Science, Tehran, Iran.

Zitieren

APA

Ameri, H., Mulhern, B., Norman, R., Shiroiwa, T., Daroudi, R., & Poder, T. G. (2025). A cross-country comparison of the psychometric performance of SF-6Dv2 and EQ-5D-5L. The European Journal of Health Economics. https://doi.org/10.1007/s10198-025-01867-3

Vancouver

Ameri H, Mulhern B, Norman R, Shiroiwa T, Daroudi R, Poder TG. A cross-country comparison of the psychometric performance of SF-6Dv2 and EQ-5D-5L. The European Journal of Health Economics. 2025. doi:10.1007/s10198-025-01867-3

BibTeX
@article{Ameri2025,
  author = {Ameri, Hosein and Mulhern, Brendan and Norman, Richard and Shiroiwa, Takeru and Daroudi, Rajabali and Poder, Thomas G},
  title = {A cross-country comparison of the psychometric performance of SF-6Dv2 and EQ-5D-5L},
  journal = {The European Journal of Health Economics},
  year = {2025},
  doi = {10.1007/s10198-025-01867-3}
}
Kostenlos starten →